1. Home
  2. OM

as 12-20-2024 3:40pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Founded: 2003 Country:
United States
United States
Employees: N/A City: SAN JOSE
Market Cap: 44.0M IPO Year: 2020
Target Price: $4.38 AVG Volume (30 days): 809.6K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.75 EPS Growth: N/A
52 Week Low/High: $0.43 - $5.88 Next Earning Date: 02-19-2025
Revenue: $114,729,000 Revenue Growth: -13.00%
Revenue Growth (this year): -11.42% Revenue Growth (next year): 10.83%

OM Daily Stock ML Predictions

Stock Insider Trading Activity of Outset Medical Inc. (OM)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Nash Marc OM SVP Operations and R&D Nov 15 '24 Sell $0.80 1,375 $1,100.00 238,022
Ahmed Nabeel OM Chief Financial Officer Nov 15 '24 Sell $0.80 4,221 $3,376.80 310,767
Trigg Leslie OM Chair and CEO Nov 15 '24 Sell $0.80 5,645 $4,516.00 904,851
Brottem John L. OM General Counsel Nov 15 '24 Sell $0.80 3,203 $2,562.40 227,092

Share on Social Networks: